… of Alzheimer's disease is not known, the β-amyloid peptide … amino acids are suspected to
contribute to the disease. The … Alzheimer's disease effectively elevated β-amyloid-40 and β-…

Research on the molecular pathogenesis of Alzheimer's disease (AD) has made great
strides over the last decade. This progress is the result of protein chemical analysis of two …

Alzheimer's disease (AD) is characterized by amyloid deposits within the neocortical parenchyma
and the cerebrovasculature. The main component of these predominantly extracellular …

… of Alzheimer's disease (AD) is a topic of debate, the consensus is that the accumulation of
β-amyloid (Aβ) … of the disease. The Aβ peptide is formed by the amyloidogenic cleavage of the …

… of Alzheimer's disease (AD) is the presence of amyloid … The principal component of amyloid
is the β‐amyloid protein (… and the extracellular domain of the amyloid precursor protein (APP)…

… meningovascular accumulation of β-amyloid in Alzheimer's disease. An … of β-amyloid
immunoreactivity in skin, intestine, and adrenal medulla in patients with Alzheimer's disease, …

… The presence of amyloid deposits in the parenchyma of the amygdala, hippocampus, and …
hallmark of Alzheimer's disease. The principal component of amyloid is amyloid beta, a 39–43 …

… β‐amyloid (Aβ) component of senile plaques may be the key molecule in the pathology of
Alzheimer's disease … the β‐amyloid peptide is the predominantly neuronal β‐amyloid precursor …

Thioflavine T (ThT) associates rapidly with aggregated fibrils of the synthetic β/A4‐derived
peptides β(1–28) and β(1–40), giving rise to a new excitation (ex) (absorption) maximum at …

Recent epidemiological studies show a strong reduction in the incidence of Alzheimer's disease
in patients treated with cholesterol-lowering statins. Moreover, elevated Aβ42 levels and …